Grant to Boost Leukemia Research
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPurdue Research Park-based Tymora Analytical Operations LLC is part of a group receiving a $300,000 grant from the National Institutes of Health. The company will team with Purdue University and St. Jude Children's Hospital to develop technology to identify different types of leukemia cells.
October 2, 2013
News Release
West Lafayette, Ind. and Memphis, Tenn. – People affected by leukemia and health care professionals who advocate for personalized medicine options could benefit from technology that is being developed with funding from a National Institutes of Health grant.
Tymora Analytical Operations LLC, Purdue University and St. Jude Children's Research Hospital (http://www.stjude.org) have been awarded a one-year, $300,000 Phase I STTR grant from the NIH. The groups will develop technology that could pinpoint the proteins inside cells affected by the disease so treatments can be more targeted.
“By showing which proteins are affected by the disease, this platform can highlight the differences between leukemia cells,” said Anton Iliuk, chief technology officer of Tymora Analytical Operations. “Identifying these differences would enable doctors to prescribe individualized, more precise drug treatment regimens for each patient.”
The new platform will be developed from the company's pIMAGO and PolyMAC technologies.
The principal investigator for the project is W. Andy Tao, associate professor of biochemistry in Purdue's College of Agriculture. He also is chief scientific officer at Tymora Analytical Operations. The co-investigator is Jun J. Yang of St. Jude Children's Research Hospital in Memphis.
About Tymora Analytical Operations LLC
Tymora Analytical Operations was established in 2010 in the Purdue Research Park to provide new nanotechnology-based products to serve the R&D market in the life sciences. Tymora has developed a nanoscale platform technology – with PolyMAC and pIMAGO as the lead products – for unmet needs in analysis of protein phosphorylation that relates to the onset of numerous diseases, most notably cancer.
About Purdue Research Park
The Purdue Research Park has the largest university-affiliated business incubation complex in the country in four locations across Indiana. The parks are home to nearly 240 companies that employ more than 4,200 people and are located in West Lafayette, Merrillville, Indianapolis and New Albany.
Source: Purdue Research Park
